NZ500577A - Human cerberus protein that regulates cell function, induce neural development or antagonise bone morphogenic proteins - Google Patents

Human cerberus protein that regulates cell function, induce neural development or antagonise bone morphogenic proteins

Info

Publication number
NZ500577A
NZ500577A NZ500577A NZ50057798A NZ500577A NZ 500577 A NZ500577 A NZ 500577A NZ 500577 A NZ500577 A NZ 500577A NZ 50057798 A NZ50057798 A NZ 50057798A NZ 500577 A NZ500577 A NZ 500577A
Authority
NZ
New Zealand
Prior art keywords
antagonise
cell function
bone morphogenic
morphogenic proteins
regulates cell
Prior art date
Application number
NZ500577A
Other languages
English (en)
Inventor
David M Valenzuela
Eduardo A Rojas
Aris N Economides
Neil E Stahl
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26721541&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ500577(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of NZ500577A publication Critical patent/NZ500577A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ500577A 1997-04-29 1998-03-31 Human cerberus protein that regulates cell function, induce neural development or antagonise bone morphogenic proteins NZ500577A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4442797P 1997-04-29 1997-04-29
US4515797P 1997-04-30 1997-04-30
PCT/US1998/006324 WO1998049296A1 (en) 1997-04-29 1998-03-31 Human cerberus protein

Publications (1)

Publication Number Publication Date
NZ500577A true NZ500577A (en) 2001-02-23

Family

ID=26721541

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ500577A NZ500577A (en) 1997-04-29 1998-03-31 Human cerberus protein that regulates cell function, induce neural development or antagonise bone morphogenic proteins

Country Status (8)

Country Link
US (2) US6610510B1 (OSRAM)
EP (1) EP0975752A1 (OSRAM)
JP (1) JP4062551B2 (OSRAM)
AU (1) AU726385B2 (OSRAM)
CA (1) CA2288373C (OSRAM)
IL (1) IL132443A0 (OSRAM)
NZ (1) NZ500577A (OSRAM)
WO (1) WO1998049296A1 (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
DE69434651T2 (de) 1993-12-07 2007-03-08 Genetics Institute, Inc., Cambridge Bmp-12, bmp-13 und diese enthaltende sehne-induzierende zusammensetzungen
WO1999061044A1 (en) * 1998-05-28 1999-12-02 The Board Of Trustees Of The University Of Arkansas Noggin and antagonists of bone morphogenetic proteins to suppress pathologic bone resorption
JP4813660B2 (ja) * 1998-11-27 2011-11-09 ダーウィン ディスカバリー リミテッド 骨鉱化作用を増加するための組成物および方法
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
ATE271886T1 (de) 1999-10-15 2004-08-15 Inst Genetics Llc Hyaluronsäure enthaltende zusammensetzungen zur abgabe osteogener proteine
WO2002099037A2 (en) 2001-06-01 2002-12-12 Wyeth Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
SG143977A1 (en) * 2001-06-05 2008-07-29 Auckland Uniservices Ltd Methods and compositions for assessment of pulmonary function and disorders
CN1538850A (zh) * 2001-06-08 2004-10-20 ʷ 用于骨或软骨再生的bmp结合蛋白
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
GB2385052A (en) 2002-02-05 2003-08-13 Leuven K U Res & Dev Treatment of spondyloarthropathies
US7193069B2 (en) * 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
US20060276385A1 (en) * 2003-01-13 2006-12-07 Hanjoong Jo Anti-inflammatory agents and methods of their use
US9045553B2 (en) 2004-05-27 2015-06-02 Acceleron Pharma, Inc. Cerberus/Coco derivatives and uses thereof
US7316998B2 (en) * 2004-05-27 2008-01-08 Acceleron Pharma Inc. Cerberus/Coco derivatives and uses thereof
US20060269946A1 (en) * 2005-05-10 2006-11-30 Young Robert P Methods and compositions for assessment of pulmonary function and disorders
AU2006248201A1 (en) * 2005-05-19 2006-11-23 Synergenz Bioscience Limited Methods for the assesssment of risk of developing lung cancer using analysis of genetic polymorphisms
JP2008545389A (ja) * 2005-05-19 2008-12-18 シナージェンズ バイオサイエンス リミティド 肺機能及び肺障害の評価のための方法及び組成物
EP1888779A4 (en) * 2005-05-20 2009-06-10 Synergenz Bioscience Ltd METHOD FOR THE ANALYSIS OF POLYMORPHISMS AND USES THEREOF
AU2007257208B2 (en) * 2006-05-17 2013-05-02 Stryker Corporation Use of a soluble morphogenic protein complex for treating cartilage defects
CA2671983A1 (en) 2006-12-08 2009-06-19 Acceleron Pharma Inc. Uses of cerberus, coco and derivatives thereof
CN105759056B (zh) * 2016-04-06 2017-11-14 四川大学华西医院 一种肺癌筛查试剂盒
US10961305B2 (en) 2016-12-21 2021-03-30 Mereo Biopharma 3 Limited Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952499A (en) * 1988-02-11 1990-08-28 Dana-Farber Cancer Institute Genes and their encoded proteins which regulate gene expression of the interleukin-2 receptor and of human lymphotropic retroviruses
US6133232A (en) * 1996-06-20 2000-10-17 The Regents Of The University Of California Endoderm, cardiac and neural inducing factors

Also Published As

Publication number Publication date
AU6873698A (en) 1998-11-24
US6610510B1 (en) 2003-08-26
JP2001526535A (ja) 2001-12-18
CA2288373C (en) 2010-06-01
JP4062551B2 (ja) 2008-03-19
CA2288373A1 (en) 1998-11-05
AU726385B2 (en) 2000-11-02
EP0975752A1 (en) 2000-02-02
IL132443A0 (en) 2001-03-19
US7241739B2 (en) 2007-07-10
US20030199042A1 (en) 2003-10-23
WO1998049296A1 (en) 1998-11-05

Similar Documents

Publication Publication Date Title
DE69827280D1 (de) Lordotisches wirbelimplantat
FR2763836B1 (fr) Cage intervertebrale cervicale
DE69624672D1 (de) Wirbelsäulenimplantat
FR2787020B1 (fr) Implant intervertebral
DE69722320D1 (de) Skelettimplantat
AU6030398A (en) Human proteins
AU4989399A (en) Bone morphogenic protein
FI960809A7 (fi) Hermoregeneraatio käyttäen ihmisen luun morfogeneettisiä proteiineja
NO965208D0 (no) Benprotese
IL132443A0 (en) Human cerberus protein
DE69715264D1 (de) Knochenprothese
PL335800A1 (en) Bone paste
ATA144897A (de) Wirbelsäulen-prothese
FR2769827B1 (fr) Implant pour arthrodese rachidienne inter-somatique
GB9719879D0 (en) Protein
GB9703681D0 (en) Protein complemention
AU2205499A (en) Human regulatory proteins
GB9822882D0 (en) Protein precipitation
ZA964821B (en) Bone stimulating factor.
AU5475199A (en) Human chordin-related proteins and polynucleotides encoding them
AU9017598A (en) Human frezzled-like protein
ZA9711148B (en) Bone stimulating factor.
PL324822A1 (en) Human protein mp52 arg
AU6267098A (en) Morphogenic proteins
DE69719724D1 (de) Kugelförmige orbitaprothese

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired